GlaxoSmithKline and Innoviva, Inc announced results from data presented at the American Thoracic Society (ATS) 2016 International Conference investigating the...
Read morePfizer announced results from the second phase of its global RA surveys, which assessed the relationship between physician-patient communication and...
Read more• Ho Chi Minh City Communities for Healthy Hearts Program is the second innovative healthcare model for hypertension ...
Read moreSwedish Orphan Biovitrum AB and Biogen announced that the European Commission (EC) has approved Alprolix® (rFIXFc), their extended half-life therapy,...
Read moreGSK presented new data for its meningococcal group B vaccine, Bexsero®,1 comparing safety...
Read moreSwedish Orphan Biovitrum AB and Biogen announced that the European Commission (EC) has approved Alprolix® (rFIXFc), their extended half-life therapy,...
Read moreMerck, a leading science and technology company, will exhibit a new range of products and solutions at Analytica 2016, the...
Read more• Detects biomarkers of horse infection, inflammation, immune response and general health • Addresses unmet needs of equine research...
Read morefizer Inc announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) approved...
Read moreAstraZeneca announced that it has completed the divestment of the global rights to Imdur, outside the US, to China Medical...
Read morePharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
© 2017 Copyright © Valuemediaservices 2017 All rights reserved.